Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Treasury Shares (2021 - 2025)

Biofrontera has reported Treasury Shares over the past 5 years, most recently at $412500.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $412500.0 for Q4 2025, down 8.33% from a year ago — trailing twelve months through Dec 2025 was $412500.0 (down 8.33% YoY), and the annual figure for FY2025 was $412500.0, down 8.33%.
  • Treasury Shares for Q4 2025 was $412500.0 at Biofrontera, roughly flat from $412500.0 in the prior quarter.
  • Over the last five years, Treasury Shares for BFRIW hit a ceiling of $343.5 million in Q2 2022 and a floor of $4771.0 in Q2 2023.
  • Median Treasury Shares over the past 5 years was $343512.0 (2022), compared with a mean of $23.1 million.
  • Biggest five-year swings in Treasury Shares: plummeted 100.0% in 2023 and later surged 9331.98% in 2024.
  • Biofrontera's Treasury Shares stood at $8504.0 in 2021, then soared by 101.98% to $17176.0 in 2022, then crashed by 72.22% to $4771.0 in 2023, then surged by 9331.98% to $450000.0 in 2024, then decreased by 8.33% to $412500.0 in 2025.
  • The last three reported values for Treasury Shares were $412500.0 (Q4 2025), $412500.0 (Q3 2025), and $450000.0 (Q2 2025) per Business Quant data.